| abstract |
Compounds having a structure of Formula I: n n n n n n n n n n or a pharmaceutically acceptable salt, tautomer, stereoisomer or deuterated analogue thereof, wherein X, R, R 1 , R 2 , R 3 , R 4 , M 1 , M 2 , L 1 , L 2 , J 1 , J 2 , a 1 , a 2 , b 1 and b 2 are as defined herein, are provided. Uses of such compounds for treatment of various indications, including prostate cancer as well as methods of treatment involving such compounds are also provided. |